Exoribonuclease 1 (ERI1) Peptide
ERI1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Quick Overview for Exoribonuclease 1 (ERI1) Peptide (ABIN938983)
Target
ERI1
(Exoribonuclease 1 (ERI1))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- GSWDMSKFLN IQCQLSRLKY PPFAKKWINI RKSYGNFYKV PRSQTKLTIM
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of THEX1 antibody,
Alternative Names: THEX1 control peptide, THEX1 antibody Blocking Peptide, Anti-THEX1 Blocking Peptide, Three Prime Histone mRNA Exonuclease 1 Blocking Peptide, THEX1, THEX-1, THEX 1, THEX-1 Blocking Peptide, THEX 1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- ERI1 (Exoribonuclease 1 (ERI1))
-
Background
- THEX1 contains 1 SAP domain and 1 exonuclease domain. It is an RNA exonuclease that binds to the 3' end of histone mRNAs and probably degrades them, suggesting that it plays an essential role in histone mRNA decay after replication. It is also able to degrade the 3' overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi).
-
Molecular Weight
- 38 kDa
Target
-
You are here:
